Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome [Phase 2]
Phase 2 trial update evaluating the combination of chemotherapy and bone marrow transplantation in patients with leukemia or myelodysplastic…
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT) [Phase 4]
This Phase 4 clinical trial update evaluates the safety and efficacy of busulfan as a conditioning regimen prior to hematopoietic cell trans…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating interferon alfa after chemotherapy and peripheral stem cell transplantation in patients with Stage III or …
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Safety and Efficacy Study of GCS-100LE in the Treatment of Multiple Myeloma [Phase 1]
Phase 1 trial update evaluating GCS-100LE for multiple myeloma has been terminated; the report covers safety and potential efficacy findings…
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer [Phase 1]
A Phase 1 clinical trial update reports completion of arsenic trioxide in patients with advanced hematologic cancers, including leukemia and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
This is a Phase 2 clinical trial update evaluating bevacizumab with or without thalidomide in relapsed or refractory multiple myeloma; the s…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluated combining MAGE-A3 and NY-ESO-1 immunotherapies with DTPACE chemotherapy and autologous transp…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer [Phase 2]
Phase 2 clinical trial update examining the combination of phenylbutyrate and azacitidine in patients with acute myeloid leukemia, myelodysp…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Interleukin-12 in Treating Patients With Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating interleukin-12 in patients with multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer [Phase 1]
This clinical trial update reports the Phase 1 safety and tolerability results of PCI-24781 in cancer patients. The study, sponsored by Phar…
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma [Phase 2]
Phase 2 trial update evaluating melphalan and filgrastim to stimulate peripheral stem cell collection in patients with multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: PS-341 in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial update of PS-341 (bortezomib) in hematologic cancers; the study has completed and includes leukemia, lymphoma, multiple myelom…
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation [NA]
This completed clinical trial evaluated whether music therapy reduces pain and emotional distress in patients with hematologic cancers under…
-
CLINICAL_TRIALS trial_result · 2013-05-31Clinical Trial Update: Bortezomib With Melphalan and Prednisone for Multiple Myeloma [Phase 2]
Phase 2 trial investigating bortezomib with melphalan and prednisone for multiple myeloma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2013-05-31Clinical Trial Update: Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma [Phase 3]
Phase 3 trial update evaluating whether adding high-dose cyclophosphamide to chemotherapy with recombinant interferon alfa-2b benefits patie…
-
CLINICAL_TRIALS trial_result · 2013-05-16Clinical Trial Update: A Post-Approval Pharmacokinetic Study of Bortezomib in Participants With Multiple Myeloma [Phase 3]
This Phase 3 clinical trial update reports pharmacokinetic data for bortezomib in participants with multiple myeloma, conducted after initia…
-
CLINICAL_TRIALS trial_result · 2013-05-16Clinical Trial Update: Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction [Phase 1]
This Phase 1 trial evaluated bortezomib in patients with advanced cancer and kidney dysfunction. The study has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma [Phase 3]
This is an update on a Phase 3 trial evaluating combination chemotherapy for stage II/III multiple myeloma that has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-10Clinical Trial Update: Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating the combination of temsirolimus (CCI-779) and bortezomib (Velcade) in relapsed or relapsed/refractory multi…
-
CLINICAL_TRIALS trial_result · 2013-05-09Clinical Trial Update: High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors [Phase 2]
Phase 2 trial evaluating high-dose chemotherapy with total-body irradiation followed by autologous stem cell or bone marrow transplantation …
-
CLINICAL_TRIALS trial_result · 2013-05-07Clinical Trial Update: A Study of Efficacy of Treatment With Bortezomib (in Combination With Doxorubicin and Dexamethasone) in Previously Untreated Patients With Multiple Myeloma [Phase 2]
Phase 2 study evaluating the efficacy of a bortezomib-based regimen (bortezomib with doxorubicin and dexamethasone) in previously untreated …
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: Evaluation of the Spectra Optia® Mononuclear Cell Collection Procedure [NA]
This update summarizes results from a clinical trial evaluating the Spectra Optia Mononuclear Cell Collection Procedure in multiple myeloma,…
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia [Phase 1]
This Phase 1 trial assessed the combination of arsenic trioxide and ascorbic acid with bortezomib, thalidomide, and dexamethasone in patient…
-
CLINICAL_TRIALS trial_result · 2013-04-25Clinical Trial Update: MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 study evaluating pomalidomide alone or with low-dose dexamethasone in relapsed/refractory multiple myeloma, reporting maximum tole…
-
CLINICAL_TRIALS trial_result · 2013-04-23Clinical Trial Update: A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma [Phase 1]
Phase I study evaluating thymoglobulin in patients with relapsed or refractory multiple myeloma; the trial is completed.